Charles F. Wagner Jr - Apr 1, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP & Chief Financial Officer
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Apr 1, 2022
Transactions value $
-$683,602
Form type
4
Date filed
4/5/2022, 04:06 PM
Previous filing
Mar 21, 2022
Next filing
May 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$78.4K -300 -0.65% $261.42 45.9K Apr 1, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$100K -381 -0.83% $263.67 45.5K Apr 1, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$303K -1.14K -2.51% $265.06 44.4K Apr 1, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$143K -536 -1.21% $265.95 43.8K Apr 1, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$59.5K -223 -0.51% $266.68 43.6K Apr 1, 2022 Direct F1, F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1.
F2 Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $261.42 (range $261.04 to $261.80).
F4 Open market sales reported on this line occurred at a weighted average price of $263.67 (range $263.45 to $264.42).
F5 Open market sales reported on this line occurred at a weighted average price of $265.06 (range $264.53 to $265.48).
F6 Open market sales reported on this line occurred at a weighted average price of $265.95 (range $265.55 to $266.47).
F7 Open market sales reported on this line occurred at a weighted average price of $266.68 (range $266.55 to $266.83).